Adherence to Advisory Committee on Immunization Practices in diabetes mellitus patients in Saudi Arabia : A multicenter retrospective study
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved..
BACKGROUND: Patients with diabetes mellitus (DM) are predisposed to an increased risk of infection signifying the importance of vaccination to protect against its potentially severe complications. The Centers for Disease Control and Prevention/Advisory Committee on Immunization Practices (CDC/ACIP) issued immunization re-commendations to protect this patient population.
AIM: To assess the adherence of patients with DM to the CDC/ACIP immunization recommendations in Saudi Arabia and to identify the factors associated with the vaccine adherence rate.
METHODS: An observational retrospective study conducted in 2023 was used to collect data on the vaccination records from 13 diabetes care centers in Saudi Arabia with 1000 eligible patients in phase I with data collected through chart review and 709 patients in phase II through online survey.
RESULTS: Among participants, 10.01% (n = 71) had never received any vaccine, while 85.89% (n = 609) received at least one dose of the coronavirus disease 2019 (COVID-19) vaccine, and 34.83% (n = 247) had received the annual influenza vaccine. Only 2.96% (n = 21), 2.11% (n = 15), and 1.12% (n = 8) received herpes zoster, tetanus, diphtheria, and pertussis (Tdap), and human papillomavirus (HPV) vaccines, respectively. For patients with DM in Saudi Arabia, the rate of vaccination for annual influenza and COVID-19 vaccines was higher compared to other vaccinations such as herpes zoster, Tdap, pneumococcal, and HPV. Factors such as vaccine recommendations provided by family physicians or specialists, site of care, income level, DM-related hospitalization history, residency site, hemoglobin A1c (HbA1c) level, and health sector type can significantly influence the vaccination rate in patients with DM. Among non-vaccinated patients with DM, the most reported barriers were lack of knowledge and fear of side effects. This signifies the need for large-scale research in this area to identify additional factors that might facilitate adherence to CDC/ACIP vaccine recommendations in patients with DM.
CONCLUSION: In Saudi Arabia, patients with DM showed higher vaccination rates for annual influenza and COVID-19 vaccines compared to other vaccinations such as herpes zoster, Tdap, pneumococcal, and HPV. Factors such as vaccine recommendations provided by family physicians or specialists, the site of care, income level, DM-related hospitalization history, residency site, HbA1c level, and health sector type can significantly influence the vaccination rate in patients with DM.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
World journal of diabetes - 15(2024), 3 vom: 15. März, Seite 440-454 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Alqifari, Saleh Fahad [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 vaccine |
|---|
| Anmerkungen: |
Date Revised 10.04.2024 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.4239/wjd.v15.i3.440 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370804279 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370804279 | ||
| 003 | DE-627 | ||
| 005 | 20240410233108.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240409s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4239/wjd.v15.i3.440 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1371.xml |
| 035 | |a (DE-627)NLM370804279 | ||
| 035 | |a (NLM)38591075 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Alqifari, Saleh Fahad |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Adherence to Advisory Committee on Immunization Practices in diabetes mellitus patients in Saudi Arabia |b A multicenter retrospective study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 10.04.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. | ||
| 520 | |a BACKGROUND: Patients with diabetes mellitus (DM) are predisposed to an increased risk of infection signifying the importance of vaccination to protect against its potentially severe complications. The Centers for Disease Control and Prevention/Advisory Committee on Immunization Practices (CDC/ACIP) issued immunization re-commendations to protect this patient population | ||
| 520 | |a AIM: To assess the adherence of patients with DM to the CDC/ACIP immunization recommendations in Saudi Arabia and to identify the factors associated with the vaccine adherence rate | ||
| 520 | |a METHODS: An observational retrospective study conducted in 2023 was used to collect data on the vaccination records from 13 diabetes care centers in Saudi Arabia with 1000 eligible patients in phase I with data collected through chart review and 709 patients in phase II through online survey | ||
| 520 | |a RESULTS: Among participants, 10.01% (n = 71) had never received any vaccine, while 85.89% (n = 609) received at least one dose of the coronavirus disease 2019 (COVID-19) vaccine, and 34.83% (n = 247) had received the annual influenza vaccine. Only 2.96% (n = 21), 2.11% (n = 15), and 1.12% (n = 8) received herpes zoster, tetanus, diphtheria, and pertussis (Tdap), and human papillomavirus (HPV) vaccines, respectively. For patients with DM in Saudi Arabia, the rate of vaccination for annual influenza and COVID-19 vaccines was higher compared to other vaccinations such as herpes zoster, Tdap, pneumococcal, and HPV. Factors such as vaccine recommendations provided by family physicians or specialists, site of care, income level, DM-related hospitalization history, residency site, hemoglobin A1c (HbA1c) level, and health sector type can significantly influence the vaccination rate in patients with DM. Among non-vaccinated patients with DM, the most reported barriers were lack of knowledge and fear of side effects. This signifies the need for large-scale research in this area to identify additional factors that might facilitate adherence to CDC/ACIP vaccine recommendations in patients with DM | ||
| 520 | |a CONCLUSION: In Saudi Arabia, patients with DM showed higher vaccination rates for annual influenza and COVID-19 vaccines compared to other vaccinations such as herpes zoster, Tdap, pneumococcal, and HPV. Factors such as vaccine recommendations provided by family physicians or specialists, the site of care, income level, DM-related hospitalization history, residency site, HbA1c level, and health sector type can significantly influence the vaccination rate in patients with DM | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 vaccine | |
| 650 | 4 | |a Diabetes mellitus | |
| 650 | 4 | |a Immunization | |
| 650 | 4 | |a Influenza vaccine | |
| 650 | 4 | |a Pneumococcal vaccine | |
| 650 | 4 | |a Retrospective study | |
| 650 | 4 | |a Vaccine recommendation | |
| 700 | 1 | |a Esmail, Aya K |e verfasserin |4 aut | |
| 700 | 1 | |a Alarifi, Dalal M |e verfasserin |4 aut | |
| 700 | 1 | |a Alsuliman, Ghalya Y |e verfasserin |4 aut | |
| 700 | 1 | |a Alhati, Maram M |e verfasserin |4 aut | |
| 700 | 1 | |a Mutlaq, May R |e verfasserin |4 aut | |
| 700 | 1 | |a Aldhaeefi, Mohammed |e verfasserin |4 aut | |
| 700 | 1 | |a Alshuaibi, Shaden A |e verfasserin |4 aut | |
| 700 | 1 | |a Amirthalingam, Palanisamy |e verfasserin |4 aut | |
| 700 | 1 | |a Abdallah, Abrar |e verfasserin |4 aut | |
| 700 | 1 | |a Wasel, Afaf S |e verfasserin |4 aut | |
| 700 | 1 | |a Hamad, Heba R |e verfasserin |4 aut | |
| 700 | 1 | |a Alamin, Shoroq |e verfasserin |4 aut | |
| 700 | 1 | |a Atia, Tasneem H |e verfasserin |4 aut | |
| 700 | 1 | |a Alqahtani, Tariq |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t World journal of diabetes |d 2010 |g 15(2024), 3 vom: 15. März, Seite 440-454 |w (DE-627)NLM207896593 |x 1948-9358 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2024 |g number:3 |g day:15 |g month:03 |g pages:440-454 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4239/wjd.v15.i3.440 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2024 |e 3 |b 15 |c 03 |h 440-454 | ||